Home » Topics » Regulatory

Regulatory
RSS

FDA approves new combination therapy product for HCV

June 4, 1998

Novartis files for U.S. marketing approval of Sandostatin LAR

June 3, 1998

FDA advisory committee recommends expanded use of Taxotere

June 2, 1998

FDA approves Aggrastat, the first platelet blocker for unstable angina

May 22, 1998

Cor's fibrinogen antagonist on the way to market

May 19, 1998

Sanofi receives expanded approval for oxaliplatin in France

May 15, 1998

Actiq trial results published; NDA amendment filed

May 11, 1998

Serono introduces Geref for treatment/diagnosis of GHD

May 8, 1998

FDA approves improved oral contraceptive agent

May 7, 1998

FDA approves test to identify risk of preterm labor

May 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...